2026-02-12
WHX Labs Dubai 2026 officially kicked off successfully at the Dubai World Trade Centre on the 10th of this month. As a company specializing in women's health diagnosis and testing, Uni-Medica showcased a portfolio of key products at the event, including the fully automated fluorescent staining test for gynecological vaginitis, the cutting-edge 15-type HPV E6/E7 mRNA full genotyping test, the 28-type HPV DNA full genotyping test, and liquid-based cytology solutions. The company delivers end-to-end solutions spanning multiple technical dimensions such as fluorescent morphology, molecular PCR, and sequencing technologies. On the first day of the exhibition, Uni-Medica's booth drew partners from across the globe for in-depth communication and exchanges, laying a solid foundation for its overseas market expansion in 2026.
Gis3100 Vaginitis Analyzer

HPV E6/E7 mRNA and DNA Full Genotyping Test
Uni-Medica's HPV E6/E7 mRNA Genotyping Detection Kit employs the fluorescent PCR melting curve method, enabling the simultaneous detection of 15 HPV E6/E7 mRNA subtypes in a single tube. Featuring a streamlined workflow, a well-established technical platform, and higher result accuracy, the kit stands out in clinical testing. Also showcased at the event is the dual-tube 28-type HPV DNA Detection Kit, which covers 12 high-risk subtypes and 16 high-prevalence subtypes. Together, these kits support the precise diagnosis and treatment of HPV-related conditions.


On the first day of the exhibition, Uni-Medica’s booth immediately attracted a large number of international partners, industry experts, and peers for visits and exchanges. With full enthusiasm and outstanding professional capabilities, the elite team of United Medical demonstrated product operations and answered questions for customers patiently and meticulously. Meanwhile, the advanced technology, superior quality, excellent functional performance and prominent advantages of the products have won high recognition and enthusiastic anticipation, fueling the further expansion of the company’s overseas business.



